abstract |
An use of an active ingredient for the preparation of a medicament, wherein the medicament is for increasing the amount of SIRT1 mRNA expression and/or reducing the amount of SOCS3 mRNA expression, in particular for regulating blood glucose, and the active ingredient is selected from the group consisting of: I) a compound, a pharmaceutically acceptable salt of a compound of formula (I), and combinations of the foregoing,n□nWherein X is H or a C1-C3 alkyl group; one of Y and Z is □nThe other is H, OH or □, where Y is □nWhen Z is □; and R1 to R13 are each independently H or OH, andnWherein, R1 to R3 are not H at the same time; R8 and R9 are not H at the same time. |